Innovative Ideas. Revolutionary Results.

EverGlade BIO connects private sector solutions to public health needs.

Who We Are

EverGlade BIO is reinvigorating the development of therapeutics for cancer and the treatment of their side effects, one important product at a time. We are committed to advancing drugs that treat cancer and minimizing the impact of cancer on lives. EverGlade BIO’s commitment extends beyond cancer treatment – we are actively engaged in developing strategies to mitigate therapy-related side effects for better patient outcomes and ensuring a more comfortable and effective treatment experience.

EverGlade BIO was founded by Eric Jia-Sobota and is comprised of pharmaceutical and clinical research executives, quality and regulatory leaders, and governmental experts. Together, we are committed to advancing innovative cancer therapies with a strong emphasis on minimizing side effects, enhancing the overall well-being of patients.

Contact Us

Scroll to Top